Prognostic value of choline and creatine in WHO grade II gliomas.
| Publicado en: | Neuroradiology Vol. 50; no. 9; pp. 759 - 768 |
|---|---|
| Autores principales: | , , , , , , , |
| Formato: | diagnostic images research tables/charts Journal Article |
| Publicado: |
Springer Nature
Sep2008
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=105559017&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 105559017 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 00283940 NYZ jtl: Neuroradiology issn: 00283940 maglogo: N pubinfo: dt: Sep2008 vid: 50 iid: 9 pid: 237 pub: Springer Nature place: New York, New York artinfo: ui: 105559017 2010062102 10.1007/s00234-008-0409-3 NLM18523762 105559017 ppf: 759 ppct: 9 formats: fmt: @attributes: type: P tig: atl: Prognostic value of choline and creatine in WHO grade II gliomas. aug: au: Hattingen E Raab P Franz K Lanfermann H Setzer M Gerlach R Zanella F Pilatus U affil: Institute of Neuroradiology, Johann Wolfgang Goethe University of Frankfurt/Main, Schleusenweg 2-16, 60528 Frankfurt/Main, Germany; elke.hattingen@kgu.de sug: subj: Glioma Classification Glioma Metabolism Magnetic Resonance Imaging Methods Neuroradiography Methods Aged Analysis of Variance Cancer Survivors Chi Square Test Choline Metabolism Creatine Metabolism Data Analysis Software Female Funding Source Glioma Diagnosis Glioma Pathology Glioma Prognosis Kaplan-Meier Estimator Male Middle Age Post Hoc Analysis Predictive Value of Tests Prospective Studies Survival Human Aged: 65+ years Middle Aged: 45-64 years Female Male pubtype: Academic Journal doctype: diagnostic images research tables/charts Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|